AUMED a.s. founded a new company AUMED Immunology a.s.. AUMED, a.s. is the sole shareholder of the newly formed company. The company AUMED Immunology a.s. was founded with the aim of registering and marketing a new medicinal product containing transfer factor as an active medicinal substance in the form of an oral lyophilized tablet. The new medicinal product will be based on the results of own research activities in the field of transfer factors (more detailed information here). The registration plan for a newly developed medicinal product belongs to the long-term business concept and strategy of AUMED, a.s..
Now you can order Phage Glow Bioactive acne gel in a new package. This revolutionary beauty product based on phage…
Our subsidiary Aumed Pharma a.s. launches a special bioactive gel intended for eczematous skin Phage Glow Skin Spray – a…
AUMED, a.s. at the beginning of 2024 opened a new workplace at the address 5. května 301, 294 71 Benátky…
Research projects of Aumed, a.s. are financed by the European Structural Funds and with financial support from the state budget through the Ministry of Industry and Trade. A complete list of all ongoing and completed projects with this support can be found here.
Ministry of Industry and Trade
Program TRIO
European Union
European Regional Development Fund
OP Enterprise and Innovation for Competitiveness
Tel.: +420 603 587 701
Komořanská 326/63, 143 14 Praha - Modřany, Česká republika
(c) 2017, Aumed a.s
